Status:
NOT_YET_RECRUITING
The Impact of a Weight Reduction Intervention on Clinical Outcomes in Patients With Obesity and COPD
Lead Sponsor:
Sahlgrenska University Hospital
Collaborating Sponsors:
Göteborg University
Conditions:
COPD
Obesity &Amp; Overweight
Eligibility:
All Genders
40-80 years
Phase:
NA
Brief Summary
Obesity and COPD are increasingly common and often coexist, worsening health outcomes such as reduced lung function, exercise capacity, and increased systemic inflammation. While COPD was historically...
Eligibility Criteria
Inclusion
- Individuals with COPD, defined by the GOLD criteria, with a forced expiratory volume in one second (FEV1) \< 80% of predicted and a forced expiratory ratio of \<70, with a BMI ≥ 30 kg/m2
Exclusion
- patients with untreated cardiac disease, renal or hepatic failure, active cancer treatment, diabetes mellitus with prescribed insulin or patients with reported unintentional weight loss in the previous three months, or physical impairment that might affect the exercise capacity.
Key Trial Info
Start Date :
September 1 2025
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
June 30 2028
Estimated Enrollment :
70 Patients enrolled
Trial Details
Trial ID
NCT07159594
Start Date
September 1 2025
End Date
June 30 2028
Last Update
September 8 2025
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.